Intracranial presentation of systemic Hodgkin's disease

被引:40
|
作者
Hirmiz, K
Foyle, A
Wilke, D
Burrell, S
Brownstone, R
Ago, C
Pahil, R
Couban, S
机构
[1] Dalhousie Univ, Dept Med, Halifax, NS B3H 2Y9, Canada
[2] Queen Elizabeth II Hlth Sci Ctr, Dept Radiat Oncol, Halifax, NS B3H 2Y9, Canada
[3] Queen Elizabeth II Hlth Sci Ctr, Dept Pathol, Halifax, NS B3H 2Y9, Canada
[4] Queen Elizabeth II Hlth Sci Ctr, Dept Diagnost Imaging, Halifax, NS B3H 2Y9, Canada
[5] Queen Elizabeth II Hlth Sci Ctr, Dept Surg, Halifax, NS B3H 2Y9, Canada
[6] Queen Elizabeth II Hlth Sci Ctr, Dept Med, Halifax, NS B3H 2Y9, Canada
[7] Cape Breton Canc Ctr, Dept Radiat Oncol, Sydney, NS, Canada
[8] Cape Breton Canc Ctr, Dept Med Oncol & Hematol, Sydney, NS, Canada
关键词
Hodgkin's disease; intracranial disease; seizure;
D O I
10.1080/10428190410001673409
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Intracranial involvement by Hodgkin's disease is rare. We report a patient with Hodgkin's disease who had intracranial disease at presentation. We also review the literature pertaining to intracranial Hodgkin's disease. Using the key words "Hodgkin's disease" and "central nervous system (CNS) disease", we searched the Pubmed and Cancerlit databases. References were systematically reviewed and data regarding the following variables was extracted: age, gender, signs and symptoms at presentation, histology of Hodgkin's disease, cerebrospinal fluid analysis, stage and treatment. Only 36 cases of intracranial Hodgkin's disease were identified in the literature. Intracranial Hodgkin's disease at presentation is even more uncommon with only 8 reported cases. Most cases of intracranial involvement by Hodgkin's disease occur at the time of relapse. The most common presenting feature of intracranial Hodgkin's disease is a cranial nerve palsy with brain parenchyma being the most common intracranial site of involvement. Mixed cellularity histology is the most frequent subtype of Hodgkin's disease among these patients and the median survival following intracranial presentation is 46 months. Treatment has varied extensively but includes whole brain radiation with or without combination chemotherapy. Our literature review suggests that the prognosis is not dismal with appropriate treatment.
引用
收藏
页码:1667 / 1671
页数:5
相关论文
共 50 条
  • [31] Primary intracranial Manifestation of Hodgkin's Disease: Case Report and Literature Overview?
    Henkenberens, C.
    Christiansen, H.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 105 - 105
  • [32] Wegener's granulomatosis of the penis: Genital presentation of systemic disease
    Al Rajabi, Wajdi
    Venturini, Marina
    Sala, Raffaella
    Calzavara-Pinton, Piergiacorno
    DERMATOLOGY, 2006, 212 (04) : 370 - 372
  • [33] Unusual presentation of Hodgkin's lymphoma
    Knibbeler-van Rossum, CTAM
    Peters, FJP
    Erdkamp, FLG
    Bos, LP
    ANNALS OF ONCOLOGY, 2002, 13 (04) : 637 - 638
  • [34] ENDOBRONCHIAL PRESENTATION OF HODGKIN'S LYMPHOMA
    Abbasi, Anna
    Chandar, Prarthna
    Shankar, Shyam
    Shamian, Ben
    Rai, Anand
    Chawla, Kabu
    Pascal, William
    CHEST, 2018, 154 (04) : 677A - 678A
  • [35] Unusual presentation of Hodgkin's lymphoma
    Dickmann, J. R. M.
    Kerstan, H.
    Heine, M.
    Morche, M.
    Austein, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 75 - 75
  • [36] A Rare Presentation of Hodgkin's Lymphoma
    Hahm, Albert
    Henry, Patricia
    DePalma, Fedele
    Elfant, Adam
    Judge, Thomas
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S310 - S310
  • [37] An Unusual Presentation of Hodgkin's Lymphoma
    Shah, M. V.
    Chandna, S.
    Bhagat, U.
    Raj, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [38] Prevalence, presentation and prognosis of lymphocyte-rich classical Hodgkin's disease
    von Wasielewski, R
    Seth, S
    Franklin, J
    Fischer, R
    Hübner, R
    Hansmann, ML
    Diehl, V
    Georgii, A
    LABORATORY INVESTIGATION, 1999, 79 (01) : 147A - 147A
  • [39] Hodgkin's disease in patients infected with HIV: Presentation, frequency and outcome.
    Tsimberidou, AM
    Sarris, AH
    Medeiros, LJ
    Mesina, O
    Hagemeister, F
    McLaughlin, P
    Rodriguez, MA
    Romaguera, J
    Cabanillas, F
    BLOOD, 1999, 94 (10) : 527A - 527A
  • [40] Major histocompatibility complex class II antigen presentation in Hodgkin's disease
    Bosshart, H
    LEUKEMIA & LYMPHOMA, 1999, 36 (1-2) : 9 - +